Morgan Stanley Avinger Inc Transaction History

Morgan Stanley

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.78 - $1.53 $8 - $16	-11 Reduced 45.83%	13 $0
Q4 2022 Feb 14, 2023	BUY	$0.96 - $19.35 $8 - $174	9 Added 60.0%	24 $0
Q3 2022 Nov 14, 2022	BUY	$1.16 - $18.45 $1 - $18	1 Added 7.14%	15 $0
Q2 2022 Oct 27, 2022	SELL	$1.44 - $3.53 $721 - $1,768	-501 Reduced 97.28%	14 $0
Q2 2022 Aug 15, 2022	SELL	$1.44 - $3.53 $721 - $1,768	-501 Reduced 97.28%	14 $0
Q1 2022 Oct 27, 2022	BUY	$3.03 - $10.2 $1,518 - $5,110	501 Added 3578.57%	515 $2,000
Q1 2022 May 13, 2022	BUY	$3.03 - $10.2 $1,560 - $5,253	515 New	515 $2,000

Ticker AVGR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 7,040,470
Market Cap $7.11M
Description
Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and internationally. It develops lumivascular platform that integrates optical coherence tomography visualiz...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.